MSGAX | NRGEX | MSGAX / NRGEX | |
Total Expense Ratio | 1.51 | 0.03 | 5,033% |
Annual Report Gross Expense Ratio | 1.60 | 0.69 | 232% |
Fund Existence | 12 years | 4 years | - |
Gain YTD | -7.662 | -2.228 | 344% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 348M | 9.27B | 4% |
Annual Yield % from dividends | 0.00 | 0.55 | - |
Returns for 1 year | -5.04 | -4.64 | 109% |
Returns for 3 years | 1.74 | 11.41 | 15% |
Returns for 5 years | -20.80 | N/A | - |
Returns for 10 years | -9.52 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
RAYD | 36.12 | 0.21 | +0.58% |
Rayliant Quantitative Dev Mkt Eq ETF | |||
PEJ | 57.77 | N/A | N/A |
Invesco Dynamic Leisure and Entmnt ETF | |||
BBC | 21.59 | N/A | N/A |
Virtus LifeSci Biotech Clinical Trls ETF | |||
OUNZ | 32.17 | -0.08 | -0.25% |
VanEck Merk Gold Trust | |||
FIXP | 19.73 | -0.05 | -0.25% |
FolioBeyond Enhanced Fixed Inc Prm ETF |